Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosis

被引:293
作者
Guidoboni, M
Gafà, R
Viel, A
Doglioni, C
Russo, A
Santini, A
Del Tin, L
Macrì, E
Lanza, G
Boiocchi, M
Dolcetti, R
机构
[1] Ctr Riferimento Oncol, Div Expt Oncol 1, I-33081 Aviano, Italy
[2] Univ Ferrara, Dept Expt & Diagnost Med, Sect Anat Pathol, I-44100 Ferrara, Italy
[3] St Anna Hosp, Div Clin Oncol, Ferrara, Italy
[4] City Hosp, Dept Pathol, Belluno, Italy
[5] Ctr Studio & Prevenz Oncol, Epidemiol Unit, Analyt Epidemiol Sect, Florence, SC USA
关键词
D O I
10.1016/S0002-9440(10)61695-1
中图分类号
R36 [病理学];
学科分类号
100104 [病理学与病理生理学];
摘要
Colorectal cancers with high-frequency microsatellite instability show peculiar clinicopathological features and a favorable clinical outcome. We investigated whether the improved prognosis for these cancers is related to the content of activated cytotoxic intraepithelial T lymphocytes. Microsatellite instability and the amount of activated cytotoxic lymphocytes were analyzed according to clinicopathological features, survival, and disease recurrence in 109 right-sided colon carcinomas from 245 consecutive patients with stage II/III colon cancer that underwent radical surgery, High-frequency microsatellite instability was found in 43% of stage II/III proximal colon cancers and was associated with significantly higher numbers of activated cytotoxic lymphocytes. High-frequency microsatellite instability, as well as the content of intratumoral-activated cytotoxic T lymphocytes correlated with improved overall and disease-free survival, particularly in patients with stage III tumors, Multivariate analysis revealed that patients with both features had a risk of death and relapse markedly lower than that associated with microsatellite status or intratumoral cytotoxic lymphocytes separately. The presence of local cytotoxic immune responses is probably the major determinant of the good clinical course of patients with microsatellite unstable colon cancer. Furthermore, high-frequency microsatellite Instability coupled with a high content of intratumoral cytotoxic lymphocytes may identify a subset of colon cancer patients with a favorable clinical outcome, particularly in stage III disease.
引用
收藏
页码:297 / 304
页数:8
相关论文
共 35 条
[1]
*AM JOINT COMM CAN, 1992, MAN STAG CANC
[2]
[Anonymous], 1995, IARC SCI PUBLICATION
[3]
Boland CR, 1998, CANCER RES, V58, P5248
[4]
Mismatch repair proficiency and in vitro response to 5-fluorouracil [J].
Carethers, JM ;
Chauhan, DP ;
Fink, D ;
Nebel, S ;
Bresalier, RS ;
Howell, SB ;
Boland, CR .
GASTROENTEROLOGY, 1999, 117 (01) :123-131
[5]
High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability [J].
Dolcetti, R ;
Viel, A ;
Doglioni, C ;
Russo, A ;
Guidoboni, M ;
Capozzi, E ;
Vecchiato, N ;
Macrì, E ;
Fornasarig, M ;
Boiocchi, M .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 154 (06) :1805-1813
[6]
Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer [J].
Elsaleh, H ;
Joseph, D ;
Grieu, F ;
Zeps, N ;
Spry, N ;
Iacopetta, B .
LANCET, 2000, 355 (9217) :1745-1750
[7]
A GENETIC MODEL FOR COLORECTAL TUMORIGENESIS [J].
FEARON, ER ;
VOGELSTEIN, B .
CELL, 1990, 61 (05) :759-767
[8]
Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer [J].
Gryfe, R ;
Kim, H ;
Hsieh, ETK ;
Aronson, MD ;
Holowaty, EJ ;
Bull, SB ;
Redston, M ;
Gallinger, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (02) :69-77
[9]
Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers [J].
Halling, KC ;
French, AJ ;
McDonnell, SK ;
Burgart, LJ ;
Schaid, DJ ;
Peterson, BJ ;
Moon-Tasson, L ;
Mahoney, MR ;
Sargent, DJ ;
O'Connell, MJ ;
Witzig, TE ;
Farr, GH ;
Goldberg, RM ;
Thibodeau, SN .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (15) :1295-1303
[10]
Microsatellite instability is a favorable prognostic indicator in patients with colorectal cancer receiving chemotherapy [J].
Hemminki, A ;
Mecklin, JP ;
Järvinen, H ;
Aaltonen, LA ;
Joensuu, H .
GASTROENTEROLOGY, 2000, 119 (04) :921-928